Effect of early administration of dexamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome: EARLY-DEX COVID-19 trial
Franco-Moreno et al., Frontiers in Medicine, doi:10.3389/fmed.2024.1385833
https://c19early.org/francomoreno.html